UGI (UGI) insider plans NYSE sale of 28,709 shares via Form 144

Rhea-AI Filing Summary

An affiliate of UGI has filed a Form 144 notice to sell 28,709 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE. The planned sale has an aggregate market value of $1,080,807.72, compared with 214,527,913 shares outstanding of the same class. The shares come from 4,936 performance stock units acquired on 09/30/2025 and 23,773 shares obtained by exercising options under a registered plan on 12/05/2025. By signing the notice, the seller represents that they are not aware of any material adverse, nonpublic information about the issuer’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	28709	1080807.72	214527913	12/05/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/30/2025	Performance Stock Units	Issuer			4936	09/30/2025	Not Applicable
Common	12/05/2025	Exercise of options under a registered plan	Issuer			23773	12/05/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the UGI Form 144 filing disclose?

The Form 144 discloses that a UGI insider intends to sell 28,709 shares of UGI common stock, with an aggregate market value of $1,080,807.72, on the NYSE.

How many UGI shares are outstanding compared to the planned Form 144 sale?

The notice states that there are 214,527,913 shares outstanding of the class of UGI common stock, compared with the 28,709 shares covered by this planned sale.

How were the UGI shares in the Form 144 acquired?

The filing shows 4,936 shares acquired on 09/30/2025 via performance stock units and 23,773 shares acquired on 12/05/2025 by exercising options under a registered plan for cash.

Which broker will handle the UGI Form 144 share sale?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, 8th Floor, New York, NY 10004, on the NYSE.

What representation does the UGI insider make in the Form 144 notice?

By signing the notice, the person for whose account the UGI securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Does the UGI Form 144 mention Rule 10b5-1 trading plans?

The text explains that if the seller adopted a written trading plan or gave trading instructions to satisfy Rule 10b5-1, then by signing and indicating the adoption date, they make the same representation as of that date.